In the STEP 1 trial extension, participants regained a substantial portion of the weight they had lost after semaglutide was withdrawn
Here are some critical aspects to keep in mind: Better Control of Blood Glucose Levels and Weight One of the main reasons patients consider switching to Tirzepatide is its potential for better blood glucose control and weight management
In older adults with type 2 diabetes mellitus (T2DM), the prevalence of sarcopenia is 23 times higher than in non-diabetic peers.1 This dual burden not only impairs physical performance and quality of life but also increases the risk of falls, frailty, and mortality.2 In recent years, growing concerns have arisen regarding the potential impact of glucose-lowering medications on muscle health, generating significant clinical debate
Each serving delivers 29+ grams of protein to support muscle growth, repair, and fullness
The DHA, DoH, and MOHAP regulatory reality BPC-157 is not an FDA-approved drug